Alain Algazi

Academic / Other · 2 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Withdrawn	Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Epstein-Barr Virus Positive, Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma	Phase 2	2020-12-01
Recruiting	Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck Cancer, Carcinoma, Squamous Cell Carcinoma	Phase 2	2019-03-08